| CCS/CHFS heart failure guidelines update: defining a new pharmacologic standard of care for heart failure with reduced ejection fraction M McDonald, S Virani, M Chan, A Ducharme, JA Ezekowitz, N Giannetti, ... Canadian Journal of Cardiology 37 (4), 531-546, 2021 | 308 | 2021 |
| Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial M Toma, CE Buller, CM Westerhout, Y Fu, WW O'Neill, DR Holmes Jr, ... European heart journal 31 (14), 1701-1707, 2010 | 289 | 2010 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 284 | 2019 |
| Testosterone supplementation in heart failure: a meta-analysis M Toma, FA McAlister, EE Coglianese, V Vidi, S Vasaiwala, JA Bakal, ... Circulation: Heart Failure 5 (3), 315-321, 2012 | 228 | 2012 |
| Transition from meeting abstract to full-length journal article for randomized controlled trials M Toma, FA McAlister, L Bialy, D Adams, B Vandermeer, PW Armstrong Jama 295 (11), 1281-1287, 2006 | 191 | 2006 |
| Modification of the relationship between simple anthropometric indices and risk factors by ethnic background SA Lear, M Toma, CL Birmingham, JJ Frohlich Metabolism 52 (10), 1295-1301, 2003 | 158 | 2003 |
| CCS/CHFS heart failure guidelines: clinical trial update on functional mitral regurgitation, SGLT2 inhibitors, ARNI in HFpEF, and tafamidis in amyloidosis E O’meara, M McDonald, M Chan, A Ducharme, JA Ezekowitz, ... Canadian Journal of Cardiology 36 (2), 159-169, 2020 | 153 | 2020 |
| Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial JA Ezekowitz, E Colin-Ramirez, H Ross, J Escobedo, P Macdonald, ... The Lancet 399 (10333), 1391-1400, 2022 | 138 | 2022 |
| Physicians' guideline adherence is associated with long‐term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international … M Komajda, J Schöpe, S Wagenpfeil, L Tavazzi, M Böhm, P Ponikowski, ... European Journal of Heart Failure 21 (7), 921-929, 2019 | 131 | 2019 |
| Cardiovascular magnetic resonance in the diagnosis of acute heart transplant rejection: a review CR Butler, R Thompson, M Haykowsky, M Toma, I Paterson Journal of Cardiovascular Magnetic Resonance 11 (1), 7, 2009 | 110 | 2009 |
| Canadian Cardiovascular Society/Canadian Heart Failure Society joint position statement on the evaluation and management of patients with cardiac amyloidosis NM Fine, MK Davis, K Anderson, DH Delgado, G Giraldeau, A Kitchlu, ... Canadian Journal of Cardiology 36 (3), 322-334, 2020 | 108 | 2020 |
| Cardiac Sarcoidosis multi-center randomized controlled trial (CHASM CS-RCT) D Birnie, RSB Beanlands, P Nery, SD Aaron, DA Culver, RA DeKemp, ... American heart journal 220, 246-252, 2020 | 95 | 2020 |
| Correlation of cardiovascular magnetic resonance imaging findings and endomyocardial biopsy results in patients undergoing screening for heart transplant rejection CR Butler, AM Savu, JA Bakal, M Toma, R Thompson, K Chow, H Wang, ... The Journal of Heart and Lung Transplantation 34 (5), 643-650, 2015 | 93 | 2015 |
| The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure: insights from the ASCEND‐HF T rial M Toma, JA Ezekowitz, JA Bakal, CM O'Connor, AF Hernandez, ... European journal of heart failure 16 (3), 334-341, 2014 | 85 | 2014 |
| Corticosteroid and immunosuppressant therapy for cardiac sarcoidosis: a systematic review S Fazelpour, MM Sadek, PB Nery, RS Beanlands, N Tzemos, M Toma, ... Journal of the American Heart Association 10 (17), e021183, 2021 | 61 | 2021 |
| Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc … S Verma, NK Dhingra, J Butler, SD Anker, JP Ferreira, G Filippatos, ... The Lancet Diabetes & Endocrinology 10 (1), 35-45, 2022 | 58 | 2022 |
| Canadian Cardiovascular Society/Canadian Cardiac Transplant Network position statement on heart transplantation: patient eligibility, selection, and post-transplantation care S Chih, M McDonald, A Dipchand, D Kim, A Ducharme, A Kaan, S Abbey, ... Canadian Journal of Cardiology 36 (3), 335-356, 2020 | 55 | 2020 |
| Palliative care in heart failure K Wiskar, M Toma, B Rush Trends in cardiovascular medicine 28 (7), 445-450, 2018 | 48 | 2018 |
| Barriers to goals of care discussions with patients who have advanced heart failure: results of a multicenter survey of hospital-based cardiology clinicians JJ You, N Aleksova, A Ducharme, J MacIver, L Mielniczuk, RA Fowler, ... Journal of cardiac failure 23 (11), 786-793, 2017 | 48 | 2017 |
| Meta-analysis of the effectiveness of heart transplantation in patients with a failing Fontan N Tabarsi, M Guan, J Simmonds, M Toma, M Kiess, V Tsang, P Ruygrok, ... The American journal of cardiology 119 (8), 1269-1274, 2017 | 45 | 2017 |
